XOLAIR Trademark

Trademark Overview

On Friday, September 5, 2003, a trademark application was filed for XOLAIR with the United States Patent and Trademark Office. The USPTO has given the XOLAIR trademark a serial number of 78296612. The federal status of this trademark filing is REGISTERED AND RENEWED as of Wednesday, March 30, 2016. This trademark is owned by NOVARTIS AG. The XOLAIR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of IgE-mediated disorders
xolair

General Information

Serial Number78296612
Word MarkXOLAIR
Filing DateFriday, September 5, 2003
Status800 - REGISTERED AND RENEWED
Status DateWednesday, March 30, 2016
Registration Number3086141
Registration DateTuesday, April 25, 2006
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 11, 2004

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of IgE-mediated disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 22, 2003
Primary Code005
First Use Anywhere DateWednesday, December 31, 2003
First Use In Commerce DateWednesday, December 31, 2003

Trademark Owner History

Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Wednesday, March 30, 2016NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Wednesday, March 30, 2016REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Wednesday, March 30, 2016REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, March 30, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, January 21, 2016TEAS SECTION 8 & 9 RECEIVED
Saturday, April 25, 2015COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, September 9, 2011NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, September 9, 2011REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, September 9, 2011CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, August 2, 2011TEAS SECTION 8 & 15 RECEIVED
Saturday, June 27, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, June 27, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 25, 2006REGISTERED-PRINCIPAL REGISTER
Wednesday, March 8, 2006LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, March 3, 2006ASSIGNED TO LIE
Wednesday, March 1, 2006ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, February 28, 2006STATEMENT OF USE PROCESSING COMPLETE
Thursday, February 2, 2006USE AMENDMENT FILED
Thursday, February 2, 2006TEAS STATEMENT OF USE RECEIVED
Tuesday, August 2, 2005EXTENSION 2 GRANTED
Tuesday, August 2, 2005EXTENSION 2 FILED
Tuesday, August 2, 2005TEAS EXTENSION RECEIVED
Monday, February 14, 2005EXTENSION 1 GRANTED
Friday, January 28, 2005EXTENSION 1 FILED
Friday, January 28, 2005TEAS EXTENSION RECEIVED
Saturday, December 4, 2004TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 18, 2004PAPER RECEIVED
Tuesday, August 3, 2004NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 11, 2004PUBLISHED FOR OPPOSITION
Wednesday, April 21, 2004NOTICE OF PUBLICATION
Monday, March 8, 2004APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 8, 2004ASSIGNED TO EXAMINER

Related Keywords

xolair disorders mediated treatment preparations pharmaceutical